Cargando…

Nations with high smoking rate have low SARS-CoV-2 infection and low COVID-19 mortality rate

BACKGROUND AND AIM OF THE WORK: The effect of tobacco smoking on COVID-19 disease is debated, with common sense and experts suggesting a deleterious effect, and manuscripts worldwide reporting a low prevalence of active tobacco smokers among intensive care unit patients. METHODS: We categorized coun...

Descripción completa

Detalles Bibliográficos
Autores principales: Landoni, Giovanni, Zangrillo, Alberto, Romero García, Carolina Soledad MStat, Faustini, Carolina, Di Piazza, Martina, Conte, Francesca, Gattarello, Simone, Kuzovlev, Artem, Likhvantsev, Valery, Puglisi, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927473/
https://www.ncbi.nlm.nih.gov/pubmed/33525216
http://dx.doi.org/10.23750/abm.v91i4.10721
_version_ 1783659675661631488
author Landoni, Giovanni
Zangrillo, Alberto
Romero García, Carolina Soledad MStat
Faustini, Carolina
Di Piazza, Martina
Conte, Francesca
Gattarello, Simone
Kuzovlev, Artem
Likhvantsev, Valery
Puglisi, Riccardo
author_facet Landoni, Giovanni
Zangrillo, Alberto
Romero García, Carolina Soledad MStat
Faustini, Carolina
Di Piazza, Martina
Conte, Francesca
Gattarello, Simone
Kuzovlev, Artem
Likhvantsev, Valery
Puglisi, Riccardo
author_sort Landoni, Giovanni
collection PubMed
description BACKGROUND AND AIM OF THE WORK: The effect of tobacco smoking on COVID-19 disease is debated, with common sense and experts suggesting a deleterious effect, and manuscripts worldwide reporting a low prevalence of active tobacco smokers among intensive care unit patients. METHODS: We categorized countries worldwide into three groups with <25%; 25-45%; >45% of active male smokers with data expressed as median and interquartile range [IQR] and extracted data on SARS-CoV-2 infections and COVID-19 deaths per million inhabitants from public available databases. We also applied multivariate regression techniques to adjust for several epidemiological factors. RESULTS: COVID-19 mortality was 13 (5-24) per million inhabitants in countries with male smokers >45% and 33 (4-133) in countries where male smokers were <25%. SARS-CoV-2 infection rates were 436 (217-954) and 1139 (302-4084) per million inhabitants with data confirmed when dividing data for each continent and when controlling for confounding factors. CONCLUSIONS: We found a counterintuitive low COVID-19 mortality and SARS-CoV-2 infection in countries with high prevalence of male smokers at the global level and within each continent, suggesting that active smoking habit is protective. Further research should urgently investigate which is the possible mechanism of action. (www.actabiomedica.it)
format Online
Article
Text
id pubmed-7927473
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-79274732021-03-04 Nations with high smoking rate have low SARS-CoV-2 infection and low COVID-19 mortality rate Landoni, Giovanni Zangrillo, Alberto Romero García, Carolina Soledad MStat Faustini, Carolina Di Piazza, Martina Conte, Francesca Gattarello, Simone Kuzovlev, Artem Likhvantsev, Valery Puglisi, Riccardo Acta Biomed Original Investigations/Commentaries BACKGROUND AND AIM OF THE WORK: The effect of tobacco smoking on COVID-19 disease is debated, with common sense and experts suggesting a deleterious effect, and manuscripts worldwide reporting a low prevalence of active tobacco smokers among intensive care unit patients. METHODS: We categorized countries worldwide into three groups with <25%; 25-45%; >45% of active male smokers with data expressed as median and interquartile range [IQR] and extracted data on SARS-CoV-2 infections and COVID-19 deaths per million inhabitants from public available databases. We also applied multivariate regression techniques to adjust for several epidemiological factors. RESULTS: COVID-19 mortality was 13 (5-24) per million inhabitants in countries with male smokers >45% and 33 (4-133) in countries where male smokers were <25%. SARS-CoV-2 infection rates were 436 (217-954) and 1139 (302-4084) per million inhabitants with data confirmed when dividing data for each continent and when controlling for confounding factors. CONCLUSIONS: We found a counterintuitive low COVID-19 mortality and SARS-CoV-2 infection in countries with high prevalence of male smokers at the global level and within each continent, suggesting that active smoking habit is protective. Further research should urgently investigate which is the possible mechanism of action. (www.actabiomedica.it) Mattioli 1885 2020 2020-11-10 /pmc/articles/PMC7927473/ /pubmed/33525216 http://dx.doi.org/10.23750/abm.v91i4.10721 Text en Copyright: © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Investigations/Commentaries
Landoni, Giovanni
Zangrillo, Alberto
Romero García, Carolina Soledad MStat
Faustini, Carolina
Di Piazza, Martina
Conte, Francesca
Gattarello, Simone
Kuzovlev, Artem
Likhvantsev, Valery
Puglisi, Riccardo
Nations with high smoking rate have low SARS-CoV-2 infection and low COVID-19 mortality rate
title Nations with high smoking rate have low SARS-CoV-2 infection and low COVID-19 mortality rate
title_full Nations with high smoking rate have low SARS-CoV-2 infection and low COVID-19 mortality rate
title_fullStr Nations with high smoking rate have low SARS-CoV-2 infection and low COVID-19 mortality rate
title_full_unstemmed Nations with high smoking rate have low SARS-CoV-2 infection and low COVID-19 mortality rate
title_short Nations with high smoking rate have low SARS-CoV-2 infection and low COVID-19 mortality rate
title_sort nations with high smoking rate have low sars-cov-2 infection and low covid-19 mortality rate
topic Original Investigations/Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927473/
https://www.ncbi.nlm.nih.gov/pubmed/33525216
http://dx.doi.org/10.23750/abm.v91i4.10721
work_keys_str_mv AT landonigiovanni nationswithhighsmokingratehavelowsarscov2infectionandlowcovid19mortalityrate
AT zangrilloalberto nationswithhighsmokingratehavelowsarscov2infectionandlowcovid19mortalityrate
AT romerogarciacarolinasoledadmstat nationswithhighsmokingratehavelowsarscov2infectionandlowcovid19mortalityrate
AT faustinicarolina nationswithhighsmokingratehavelowsarscov2infectionandlowcovid19mortalityrate
AT dipiazzamartina nationswithhighsmokingratehavelowsarscov2infectionandlowcovid19mortalityrate
AT contefrancesca nationswithhighsmokingratehavelowsarscov2infectionandlowcovid19mortalityrate
AT gattarellosimone nationswithhighsmokingratehavelowsarscov2infectionandlowcovid19mortalityrate
AT kuzovlevartem nationswithhighsmokingratehavelowsarscov2infectionandlowcovid19mortalityrate
AT likhvantsevvalery nationswithhighsmokingratehavelowsarscov2infectionandlowcovid19mortalityrate
AT puglisiriccardo nationswithhighsmokingratehavelowsarscov2infectionandlowcovid19mortalityrate